Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Untitled Letter
  6. /
  7. Novartis Pharmaceuticals Corporation
UNTITLED LETTER
•Novartis Pharmaceuticals Corporation•August 8, 2023

FDA UNTITLED_LETTER - Novartis Pharmaceuticals Corporation - August 08, 2023

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This UNTITLED LETTER record concerns Novartis Pharmaceuticals Corporation, with an inspection on August 8, 2023.

Company
Novartis Pharmaceuticals Corporation
Inspection Date
August 8, 2023
Person
  • Alexander Lopez (Director of Compliance Branch)
Open in Dashboard

ID · cd26624a-3912-48a5-979f-444b80110332

Violation Codes8
21 CFR 21021 CFR 21121 CFR 211.113(b)21 CFR 211.100(a)21 CFR 211.160(b)FD&C Act 501(a)(2)(B)21 CFR 211.42(c)21 CFR 601.12

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.